Grik4 Glutamate Receptor Kainate Type Subunit 4 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mermaid diagram (expand to render)
GRIK4 (Glutamate Ionotropic Kainate Type Subunit 4) encodes the GluR8 (also known as KA1) kainate receptor subunit, a high-affinity kainate receptor. Kainate receptors are ionotropic glutamate receptors that mediate excitatory neurotransmission and modulate neural circuit function. GRIK4 produces multiple splice variants with distinct functional properties. Unlike other kainate receptor subunits that can form functional homomeric receptors, GRIK4 (KA1) requires co-assembly with GRIK5 (KA2) to form functional receptors in most neuronal cell types. This subunit is uniquely characterized by its exceptionally high affinity for glutamate, making it sensitive to ambient glutamate concentrations in the extracellular space. [@lerma2022]
Gene Information
Protein Structure
GluR8 contains the canonical ionotropic glutamate receptor architecture:
Extracellular Domains
Amino-terminal domain (ATD): The large extracellular ATD (~400 aa) is responsible for receptor assembly, dimerization, and allosteric modulation. It contains leucine-rich repeats (LRR) and forms a bilobed structure that interacts with neighboring subunits.
Ligand-binding domain (LBD): The LBD (~300 aa) adopts a clamshell-like structure with two lobes (S1 and S2) that bind glutamate. The high affinity of GluR8 for kainate and glutamate is determined by specific residues in the binding pocket.
Transmembrane and Intracellular Domains
Transmembrane domain (TMD): Three hydrophobic helices (M1, M3, M4) span the membrane, with M2 forming the pore loop that determines ion selectivity (permeable to Na+ and K+, with some Ca2+ permeability).
C-terminal tail (CTD): The intracellular CTD contains:
PDZ-binding motif for scaffold protein interactions
Multiple phosphorylation sites (Ser, Thr, Tyr)
Sites for protein kinase C (PKC), CaMKII, and src kinase regulation
Normal Function
High-Affinity Kainate Receptors
GluR8-containing receptors have unique pharmacological and biophysical properties:
High affinity: Kd ~50 nM for glutamate, making it sensitive to low ambient glutamate
Slow desensitization: Distinct desensitization kinetics from AMPA receptors
Voltage dependence: Shows partial conductance at resting membrane potential
Presynaptic modulation: Regulates neurotransmitter release at presynaptic terminals
Metabotropic signaling: Can activate G-protein coupled signaling cascades
Brain Distribution
GRIK4 exhibits region-specific expression:
[Hippocampus](/brain-regions/hippocampus): High expression in CA1 region and dentate gyrus
Cerebral [cortex](/brain-regions/cortex): Layer-specific expression, particularly layer II
Amygdala: Moderate expression in basolateral and medial nuclei
Cerebellum: Lower expression in granule and molecular layers
Thalamus: Expression in specific relay nuclei
Receptor Assembly
GRIK4 (KA1) primarily forms heteromeric receptors with GRIK5 (KA2)
The GRIK4/GRIK5 receptors are predominantly extrasynaptic
They respond to glutamate spillover from synaptic clefts
May function as sensors of ambient glutamate levels
Signaling Mechanisms
Ionotropic Signaling
Na+ influx causes membrane depolarization
Ca2+ influx through the pore (more than AMPA receptors)
Activation of voltage-gated calcium channels
Triggering of intracellular calcium-dependent cascades
Metabotropic Signaling
Can activate Gq-coupled signaling in some contexts
Modulation of adenylate cyclase activity
Regulation of MAPK/ERK signaling pathways
Interaction with PDZ domain proteins (GRIP, PICK1)
Disease Associations
Alzheimer's Disease
Excitotoxicity: Dysregulated glutamate signaling contributes to excitotoxic neuronal death
Synaptic dysfunction: Alterations in kainate receptor-mediated plasticity
Therapeutic targeting: GRIK4 modulators may protect against excitotoxicity
Parkinson Disease
Dopaminergic system modulation: Kainate receptors modulate dopamine release
Changed sensitivity to kainic acid-induced seizures
Transgenic Models
Overexpression of GluR8 affects synaptic transmission
Used to study kainate receptor function
Research Directions
Developing selective GRIK4 modulators
Understanding GRIK4 role in psychiatric diseases
Investigating GRIK4 as biomarker
Exploring gene therapy approaches
Background
The study of Grik4 Glutamate Receptor Kainate Type Subunit 4 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[Contractor A, et al, Kainate receptors acting as presynaptic modulators (2021)](https://pubmed.ncbi.nlm.nih.gov/34082156/)
[Lerma J, et al, Kainate receptor physiology (2022)](https://pubmed.ncbi.nlm.nih.gov/34583567/)
[Mulle C, et al, Kainate receptors in the hippocampus (2020)](https://pubmed.ncbi.nlm.nih.gov/32818523/)
[Jane DE, et al, Kainate receptor subunit composition (2021)](https://pubmed.ncbi.nlm.nih.gov/33246189/)
[Hu Y, et al, GRIK4 and antidepressant response (2023)](https://pubmed.ncbi.nlm.nih.gov/36932145/)
Pathway Diagram
The following diagram shows the key molecular relationships involving GRIK4 - Glutamate Receptor Kainate Type Subunit 4 discovered through SciDEX knowledge graph analysis: